Efficacy of Mifepristone in Males With Type 2 Diabetes Mellitus

Phase 2 Terminated 8 enrolled Charles Drew University of Medicine and Science

RandomizedParallel-groupDouble-blindTreatment

Summary

Randomized, double blind, placebo-controlled clinical trial examining the efficacy and safety of mifepristone 600 mg daily in male subjects with type 2 diabetes mellitus, not associated with Cushing's syndrome

Timeline

Start: 2017-02-03
Primary completion: 2021-03-31
Completion: 2021-05-31

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Mifepristone	Small molecule	600 mg	Oral

Efficacy of Mifepristone in Males With Type 2 Diabetes Mellitus

Summary

Timeline

Drugs

Indications